IGF2 and cancer: This result contrasts with the literature, which indicates that IGF1R overexpression is a feature of many cancers [43] and that MEF cells with LOI at 11p15 (the classic mechanism for IGF2 overexpression) express more IGF1R and INSR than cells without LOI [44].